Lenox Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Lenox Wealth Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20	Closed	-$1K	–	653
2020 Q1	$1K	Hold	20	–	–	﹤0.01%	678
2019 Q4	$2K	Buy	+20	New	+$1.76K	﹤0.01%	595

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lenox Wealth Advisors's EXAS Position: Q2 2020 in Review

Lenox Wealth Advisors sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 20 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in EXAS in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q4 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

Lenox Wealth Advisors reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
Lenox Wealth Advisors sold 20 Exact Sciences shares in Q2 2020, an estimated $1K.
Lenox Wealth Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 2 quarters.
Lenox Wealth Advisors's Exact Sciences position peaked at $2K in Q4 2019.
513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Lenox Wealth Advisors's 13F filing for Q2 2020, filed 14 Jul 2020.